NCT00454090View on ClinicalTrials.gov

AZD8330 First Time in Man in Patients With Advanced Malignancies

PHASE1CompletedINTERVENTIONAL

Enrollment

83

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

October 31, 2010

Study Completion Date

March 31, 2011

Conditions

Cancer

Interventions

DRUG

AZD8330

oral tablet

Trial Locations (3)

Unknown

Research Site, Philadelphia

Research Site, Houston

Research Site, Oslo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY